BCV-18265-51103
4 vaccinations
5 coded responses
9 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 020 / MA
- Registered
- 2022-05-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-28
Dose 1 — Moderna
-
2021-04-25
Dose 2 — Moderna
-
2021-11-18
Dose 3 — Moderna
-
2022-04-26
Dose 4 — Moderna
-
2022-05-06
Registered in v-safe
-
2022-05-09
Survey response — day 7, dose 4MedDRA: Pruritus, Vaccine positive rechallenge — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: I've had itchiness on my chest after Dose 2, 3, and 4MedDRA releases: 2024-11 · check-in free text available
-
2022-05-10
Survey response — day 14, dose 4MedDRA: Rash, Rash pruritic, Vaccine positive rechallenge — Feeling: GoodFree text: Itchy chest rash continues. Same symptom as with vaccine #2 and booster #1. I don't remember if I had the rash after my vaccine. #1.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-17
Survey response — day 21, dose 4MedDRA: Rash, Rash pruritic — Feeling: GoodFree text: Back rash was increasingly itchy. Yesterday it started to subside. Chest rash no longer is itchy.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-24
Survey response — day 28, dose 4MedDRA: COVID-19, Rash — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: I have Covid. I'm taking Paxlovid. The chest rash has returned, although not as prominently as initially. Back rash has not.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-24
Report sent to call center — day 28, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-05-25
- 2022-05-31
-
2022-05-31
Call successfulParticipant prefers to complete VAERS report online
- 2022-06-07
- 2022-07-26
- 2022-10-27
-
2023-04-26
Survey response — 12 months, dose 4MedDRA: COVID-19, Exposure to SARS-CoV-2, Patient isolation — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-28 | Moderna | No |
| 2 | 2021-04-25 | Moderna | No |
| 3 | 2021-11-18 | Moderna | No |
| 4 | 2022-04-26 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 11 — day 7, dose 4
Systemic reaction (other): I've had itchiness on my chest after Dose 2, 3, and 4
Release 11 — day 14, dose 4
Symptoms: Itchy chest rash continues. Same symptom as with vaccine #2 and booster #1. I don't remember if I had the rash after my vaccine. #1.
Release 11 — day 21, dose 4
Symptoms: Back rash was increasingly itchy. Yesterday it started to subside. Chest rash no longer is itchy.
Release 11 — day 28, dose 4
Symptoms: I have Covid. I'm taking Paxlovid. The chest rash has returned, although not as prominently as initially. Back rash has not.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Patient isolation | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Rash pruritic | · | · | ✓ |
| SD | Vaccine positive rechallenge | · | · | ✓ |
| SRO | Pruritus | · | · | ✓ |
| SRO | Vaccine positive rechallenge | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release